株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

頭頸部癌:パイプライン製品の分析

Head And Neck Cancer - Pipeline Review, H2 2018

発行 Global Markets Direct 商品コード 351248
出版日 ページ情報 英文 2001 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.74円で換算しております。
Back to Top
頭頸部癌:パイプライン製品の分析 Head And Neck Cancer - Pipeline Review, H2 2018
出版日: 2018年10月30日 ページ情報: 英文 2001 Pages
概要

頭頸部癌とは、頭部あるいは頸部(鼻腔、副鼻洞、唇、口、唾液腺、のどまたは喉頭)の領域で発生する癌です。この癌の一般的な症状には、喉の持続的な痛み、嚥下に伴う痛みや困難、持続的な嗄声や変声、耳の痛み、口内や喉の出血などがあります。化学療法や放射線治療で管理します。

当レポートでは、頭頚部癌の治療薬開発パイプラインの現況と最新アップデートによる各開発段階の比較分析、企業や研究機関によって開発中の治療薬、治療薬の評価、後期段階および中止されたプロジェクトに関する情報などを提供しています。

イントロダクション

頭頚部癌の概要

治療薬の開発

頭頚部癌:治療薬の評価

頭頚部癌の治療薬開発に従事している企業

薬剤プロファイル

頭頚部癌:休止中のプロジェクト

頭頚部癌:開発が中止された製品

頭頚部癌:製品開発のマイルストーン

付録

図表一覧

図表

List of Tables

  • Number of Products under Development for Head And Neck Cancer, H2 2018
  • Number of Products under Development by Companies, H2 2018
  • Number of Products under Development by Universities/Institutes, H2 2018
  • Products under Development by Companies, H2 2018
  • Products under Development by Universities/Institutes, H2 2018
  • Number of Products by Stage and Target, H2 2018
  • Number of Products by Stage and Mechanism of Action, H2 2018
  • Number of Products by Stage and Route of Administration, H2 2018
  • Number of Products by Stage and Molecule Type, H2 2018
  • Head And Neck Cancer - Pipeline by 4SC AG, H2 2018
  • Head And Neck Cancer - Pipeline by AbbVie Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Abion Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Adaptimmune Therapeutics Plc, H2 2018
  • Head And Neck Cancer - Pipeline by ADC Therapeutics SA, H2 2018
  • Head And Neck Cancer - Pipeline by Admedus Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by Aduro BioTech Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Advaxis Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Advenchen Laboratories LLC, H2 2018
  • Head And Neck Cancer - Pipeline by Affimed GmbH, H2 2018
  • Head And Neck Cancer - Pipeline by Alkermes Plc, H2 2018
  • Head And Neck Cancer - Pipeline by Altor BioScience Corp, H2 2018
  • Head And Neck Cancer - Pipeline by Ambrx Inc, H2 2018
  • Head And Neck Cancer - Pipeline by amcure GmbH, H2 2018
  • Head And Neck Cancer - Pipeline by Amgen Inc, H2 2018
  • Head And Neck Cancer - Pipeline by AMI Onco Theranostics LLC, H2 2018
  • Head And Neck Cancer - Pipeline by Apexigen Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Arcus Biosciences Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Argenx SE, H2 2018
  • Head And Neck Cancer - Pipeline by ArQule Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Array BioPharma Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Ascentage Pharma Group Corp Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by Astellas Pharma Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2018
  • Head And Neck Cancer - Pipeline by AstraZeneca Plc, H2 2018
  • Head And Neck Cancer - Pipeline by Atara Biotherapeutics Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Aurigene Discovery Technologies Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Bayer AG, H2 2018
  • Head And Neck Cancer - Pipeline by BeiGene Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by Benitec Biopharma Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by Bexion Pharmaceuticals LLC, H2 2018
  • Head And Neck Cancer - Pipeline by Biohaven Pharmaceutical Holding Company Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by BioLineRx Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by Biomics Biotechnologies Co Ltd, H2 2018
  • Head And Neck Cancer - Pipeline by Bionovis SA, H2 2018
  • Head And Neck Cancer - Pipeline by BioNTech AG, H2 2018
  • Head And Neck Cancer - Pipeline by Biothera Pharmaceutical Inc, H2 2018
  • Head And Neck Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2018
  • Head And Neck Cancer - Pipeline by Boston Biomedical Inc, H2 2018

List of Figures

  • Number of Products under Development for Head And Neck Cancer, H2 2018
  • Number of Products under Development by Companies, H2 2018
  • Number of Products under Development by Universities/Institutes, H2 2018
  • Number of Products by Top 10 Targets, H2 2018
  • Number of Products by Stage and Top 10 Targets, H2 2018
  • Number of Products by Top 10 Mechanism of Actions, H2 2018
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
  • Number of Products by Top 10 Routes of Administration, H2 2018
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2018
  • Number of Products by Top 10 Molecule Types, H2 2018
  • Number of Products by Stage and Top 10 Molecule Types, H2 2018
目次
Product Code: GMDHC10881IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2018, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

Head and Neck Cancer is a cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx). The common symptoms of cancer of the head and neck include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. The disease may be controlled by chemotherapy and radiation therapy.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Head And Neck Cancer - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Head And Neck Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 17, 134, 143, 5, 89, 23 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical, Discovery and Unknown stages comprises 9, 8, 1, 19, 4 and 1 molecules, respectively.

Head And Neck Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Head And Neck Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Head And Neck Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Head And Neck Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Head And Neck Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Head And Neck Cancer (Oncology)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Head And Neck Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Head And Neck Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • Table of Contents
  • Introduction
  • Head And Neck Cancer - Overview
  • Head And Neck Cancer - Therapeutics Development
  • Head And Neck Cancer - Therapeutics Assessment
  • Head And Neck Cancer - Companies Involved in Therapeutics Development
  • Head And Neck Cancer - Drug Profiles
  • Head And Neck Cancer - Dormant Projects
  • Head And Neck Cancer - Discontinued Products
  • Head And Neck Cancer - Product Development Milestones
  • Appendix
Back to Top